Last updated: 24 January 2018 at 3:33am EST

Sciences Ii L Pptv Iv, L.P.... Net Worth




The estimated Net Worth of Sciences Ii L Pptv Iv, L.P.... is at least 12.7 百万$ dollars as of 5 September 2017. Sciences P owns over 176,000 units of Apollo Endosurgery Inc stock worth over 12,669,090$ and over the last 7 years Sciences sold APEN stock worth over 0$.

Sciences P APEN stock SEC Form 4 insiders trading

Sciences has made over 1 trades of the Apollo Endosurgery Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Sciences bought 176,000 units of APEN stock worth 684,640$ on 5 September 2017.

The largest trade Sciences's ever made was buying 176,000 units of Apollo Endosurgery Inc stock on 5 September 2017 worth over 684,640$. On average, Sciences trades about 176,000 units every 0 days since 2017. As of 5 September 2017 Sciences still owns at least 1,266,909 units of Apollo Endosurgery Inc stock.

You can see the complete history of Sciences P stock trades at the bottom of the page.



Insiders trading at Apollo Endosurgery Inc

Over the last 12 years, insiders at Apollo Endosurgery Inc have traded over 3,882,241$ worth of Apollo Endosurgery Inc stock and bought 10,717,094 units worth 45,588,363$ . The most active insiders traders include Holdings A/S NovoNeil GagnonR Kent Jr Mc Gaughy. On average, Apollo Endosurgery Inc executives and independent directors trade stock every 41 days with the average trade being worth of 2,726,880$. The most recent stock trade was executed by Jeffrey G. Black on 25 February 2022, trading 40,000 units of APEN stock currently worth 229,200$.



What does Apollo Endosurgery Inc do?

Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.



Complete history of Sciences P stock trades at Apollo Endosurgery Inc

インサイダー
取引
取引
合計金額
Sciences Ii L Pptv Iv, L.P....
購入する 684,640$
5 Sep 2017


Apollo Endosurgery Inc executives and stock owners

Apollo Endosurgery Inc executives and other stock owners filed with the SEC include: